http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108771728-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
filingDate 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108771728-B
titleOfInvention Application of radix pseudostellariae to preparation of antifungal drugs
abstract The invention discloses application of radix pseudostellariae to preparation of an antifungal drug, and belongs to the technical field of medicines. In vitro cell experiments show that the radix paridis has different degrees of antifungal and even antifungal effects on drug-resistant candida albicans 103, candida albicans SC5314, cryptococcus neoformans, candida krusei, candida parapsilosis, candida glabrata and candida tropicalis, so that the radix paridis can be used as an antifungal drug. The invention opens up a new application of the radix pseudostellariae, and the application of the radix pseudostellariae in preparing antifungal medicines provides a new candidate medicine for treating fungal infection. At present, the clinical antifungal spectrum is wide, the number of drugs with antifungal activity is very small, and the characteristics of the wide antifungal spectrum and the antifungal activity of the radix notoginseng are provided under the conditions that the clinical fungal drug resistance is increasingly common and the drug resistance degree is increasingly serious, so that a new treatment way is provided for the clinical high-efficiency treatment of the infection of fungi and even drug-resistant fungi.
priorityDate 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449608541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21896462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702

Total number of triples: 21.